Tratamiento de las taquicardias
- Gaztañaga Arantzamendi, L.
- Elizondo Rua, I.
- Arcocha Torres, María Fe
- Ormaetxe Merodio, José Miguel
ISSN: 0304-5412
Year of publication: 2013
Series: 11
Issue: 38
Pages: 2306-2315
Type: Article
More publications in: Medicine: Programa de Formación Médica Continuada Acreditado
Sustainable development goals
Abstract
Management of acute episode is the goal treatment in patients with sustained tachycardia. Long-term objetive is to prevent and/or control new arrhythmic episodes and avoiding sudden death in malignant ventricular arrhythmias. Patient's pattern of presentation and hemodynamic tolerance provide knowledge for the initial management. According to these data, decisions will be made to reverse the arrhythmia by external cardioversion or antiarrhythmic drugs. Once the acute phase has been solved, the arrhythmia should be evaluated to prevent further episodes. Long-term tachycardia management options have evolved considerably in recent decades, and catheter ablation has substitued antirrhytmic drugs as definitive treatment. On the other hand, implantable cardioverter-defibrillators (ICDs) are standard therapy in patients with a risk of sudden death due to a malignant ventricular arrhythmias.